Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026)
Nexalin Technology's (NXL) quarterly Change in Acquisitions & Divestments came in at $5.6 million in Q1 2026, down 13.95% year-on-year from $6.5 million in Q1 2025, and down 41.03% quarter-over-quarter from $9.5 million in Q4 2025.
Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Nexalin Technology's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 13.95% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $39.8 million, a 18.91% increase from a year earlier, with the FY2025 full-year figure at $40.7 million, up 22.58% from the prior year.
- Change in Acquisitions & Divestments retreated to $5.6 million in Q1 2026 per NXL's latest filing, from $9.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $13.5 million in Q3 2025 and bottomed at $2.9 million in Q2 2024.
- The 4-year median for Change in Acquisitions & Divestments is $9.6 million (2023), against an average of $9.3 million.
- Across the five-year window, Change in Acquisitions & Divestments slumped 69.29% in 2024 and soared 281.83% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $8.6 million in 2023, then gained by 26.36% to $10.9 million in 2024, then declined by 12.85% to $9.5 million in 2025, then plunged by 41.03% to $5.6 million in 2026.
- Per Business Quant, the three latest NXL Change in Acquisitions & Divestments figures stand at $5.6 million (Q1 2026), $9.5 million (Q4 2025), and $13.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Nexalin Technology | 9.07 Mn | 6.36 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.59 Mn |
| Mar 31, 2026 | 5.59 Mn |
| Dec 31, 2025 | 9.48 Mn |
| Dec 31, 2025 | 9.48 Mn |
| Sep 30, 2025 | 13.55 Mn |
| Sep 30, 2025 | 13.55 Mn |
| Jun 30, 2025 | 11.21 Mn |
| Jun 30, 2025 | 11.21 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 10.88 Mn |
| Dec 31, 2024 | 10.88 Mn |
| Sep 30, 2024 | 13.18 Mn |
| Sep 30, 2024 | 13.18 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Dec 31, 2023 | 8.61 Mn |
| Dec 31, 2023 | 8.61 Mn |